VIGL
USDVigil Neuroscience Inc. Common Stock
Цена в режиме реального времени
График цен
Ключевые показатели
Рыночные показатели
Открытие
$7.870
Максимум
$7.880
Минимум
$7.840
Объем
3.58M
Фундаментальные показатели компании
Рыночная капитализация
367.3M
Отрасль
Биотехнология
Страна
United States
Статистические данные торговли
Средний объем
1.10M
Биржа
NMS
Валюта
USD
52-недельный диапазон
Связанные новости
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HURA and VIGL on Behalf of Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LSEA, FARO, TASK, VIGL on Behalf of Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
VIGIL SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation into Fairness of Vigil Neuroscience, Inc. (NASDAQ: VIGL) Proposed Shareholder Buyout and Encourages Investors to Contact the Firm
The law firm of Kaskela Law LLC announces that it is investigating the fairness of the recently announced proposed buyout of Vigil Neuroscience, Inc. ...
Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
WATERTOWN, Mass., June 04, 2025 (GLOBE NEWSWIRE) -- Vigil Neuroscience, Inc. (NASDAQ:VIGL), a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, AXL, SWTX, VIGL on Behalf of Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Stifel Downgrades Vigil Neuroscience to Hold, Lowers Price Target to $8
Stifel analyst Paul Matteis downgrades Vigil Neuroscience from Buy to Hold and lowers the price target from $11 to $8.
HC Wainwright & Co. Downgrades Vigil Neuroscience to Neutral, Lowers Price Target to $8
HC Wainwright & Co. analyst Andrew Fein downgrades Vigil Neuroscience from Buy to Neutral and lowers the price target from $14 to $8.
Связанные акции
Оставаться в курсе
Установите ценовой сигнал, получите обновления анализа ИИ и новости рынка в режиме реального времени.